Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 517.75 INR
Change Today -61.50 / -10.62%
Volume 67.5K
As of 6:17 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

sequent scientific ltd (SEQ) Snapshot

Open
590.00
Previous Close
579.25
Day High
595.00
Day Low
511.00
52 Week High
04/15/15 - 683.50
52 Week Low
05/19/14 - 220.00
Market Cap
15.8B
Average Volume 10 Days
55.2K
EPS TTM
-3.75
Shares Outstanding
30.5M
EX-Date
09/16/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SEQUENT SCIENTIFIC LTD (SEQ)

Related News

No related news articles were found.

sequent scientific ltd (SEQ) Related Businessweek News

No Related Businessweek News Found

sequent scientific ltd (SEQ) Details

SeQuent Scientific Limited operates as an integrated pharmaceutical company in India and internationally. It produces human and animal health active pharmaceutical ingredients (APIs). The company’s human APIs portfolio covers anti-malarial, anthelmintic, anti-infective, antiviral, niche CVS, CNS, and dermatology therapeutic segments; and animal health APIs covers anthelmintic, antiprotozoal, nutraceutical, NSAID, anti-infective, dermatology, and other therapeutic segments. The company also provides specialized analytical solutions to technical and regulatory problems. It also manufactures a range of veterinary products in finished dosage form for use in the therapeutic category. In addition, the company provides contract research and custom synthesis, contract manufacturing, and custom process development services, as well as specialty chemicals for various industries. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to SeQuent Scientific Limited in October 2009. SeQuent Scientific Limited was incorporated in 1985 and is headquartered in Bengaluru, India.

1,100 Employees
Last Reported Date: 09/8/14
Founded in 1985

sequent scientific ltd (SEQ) Top Compensated Officers

Executive Director, Member of Audit Committee...
Total Annual Compensation: 12.5M
Compensation as of Fiscal Year 2014.

sequent scientific ltd (SEQ) Key Developments

Sequent Scientific Ltd. Reports Unaudited Standalone and Consolidated Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Sequent Scientific Ltd. reports unaudited standalone and consolidated earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, on standalone basis, the company reported total income from operations (net) of INR 1,058.560 million compared to INR 1,036.630 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 149.040 million compared to loss from operations before other income, finance costs and exceptional items of INR 132.510 million a year ago. Loss from ordinary activates before tax was INR 185.530 million compared to INR 686.480 million a year ago. Net loss was INR 202.510 million or INR 6.64 per basic and diluted share before and after extraordinary items (not annualized) compared to INR 686.480 million or INR 25.31 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the year, on standalone basis, the company reported total income from operations (net) of INR 4,448.160 million compared to INR 4,450.840 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 342.410 million compared to loss from operations before other income, finance costs and exceptional items of INR 198.510 million a year ago. Profit from ordinary activates before tax was INR 430.050 million compared to loss from ordinary activates before tax of INR 1,144.160 million a year ago. Net profit was INR 413.070 million or INR 12.22 per basic and diluted share before and after extraordinary items (not annualized) compared to net loss of INR 1,144.160 million or INR 44.28 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the quarter, on consolidated basis, the company reported total income from operations (net) of INR 1,329.206 million compared to INR 1,066.336 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 100.672 million compared to loss from operations before other income, finance costs and exceptional items of INR 178.735 million a year ago. Loss from ordinary activates before tax was INR 163.788 million compared to INR 798.705 million a year ago. Net loss was INR 190.368 million or INR 7.09 per basic and diluted share before and after extraordinary items (not annualized) compared to INR 799.115 million or INR 29.46 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the year, on consolidated basis, the company reported total income from operations (net) of INR 4,653.645 million compared to INR 4,554.654 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 124.339 million compared to INR 158.070 million a year ago. Loss from ordinary activates before tax was INR 83.679 million compared to INR 1,099.150 million a year ago. Net loss was INR 117.579 million or INR 3.75 per basic and diluted share before and after extraordinary items (not annualized) compared to INR 1,104.940 million or INR 42.76 per basic and diluted share before and after extraordinary items (not annualized) a year ago.

Sequent Scientific Ltd. to Report Fiscal Year 2015 Results on Apr 24, 2015

Sequent Scientific Ltd. announced that they will report fiscal year 2015 results on Apr 24, 2015

Sequent Scientific Ltd., Board Meeting, Apr 24, 2015

Sequent Scientific Ltd., Board Meeting, Apr 24, 2015. Agenda: To consider the audited financial results of the company for the year ended March 31, 2015; and declaration of dividend, if any, for the financial year 2014-15.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SEQ:IN 517.75 INR -61.50

SEQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SEQ.
View Industry Companies
 

Industry Analysis

SEQ

Industry Average

Valuation SEQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.5x
Price/Book 11.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENT SCIENTIFIC LTD, please visit www.sequent.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.